Search research articles
Contact Us
Filters
Showing results (611-620 of 633) with videos related to
Page
of 64
Sort By:
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
The American Journal of Surgical Pathology
|
June 8, 2018
Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists
Sean R Williamson, Priya Rao, Ondrej Hes, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 28, 2024
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia
Tao-Yan Lin, Jun-Shuang Jia, Wei-Ren Luo, et al.
The American Journal of Surgical Pathology
|
September 17, 2016
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma
Steven C Smith, Kiril Trpkov, Ying-Bei Chen, et al.
Science Translational Medicine
|
April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome
Zi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Journal of Medicinal Chemistry
|
June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials
Thomas H Marsilje, Wei Pei, Bei Chen, et al.
Cancer Discovery
|
June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Phillip M Rappold, Lynda Vuong, Josef Leibold, et al.
The American Journal of Surgical Pathology
|
January 9, 2018
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma
Chisato Ohe, Steven C Smith, Deepika Sirohi, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 633) with videos related to
Sort By:
Page
of 64
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
The American Journal of Surgical Pathology
|
June 8, 2018
Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists
Sean R Williamson, Priya Rao, Ondrej Hes, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 28, 2024
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia
Tao-Yan Lin, Jun-Shuang Jia, Wei-Ren Luo, et al.
The American Journal of Surgical Pathology
|
September 17, 2016
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma
Steven C Smith, Kiril Trpkov, Ying-Bei Chen, et al.
Science Translational Medicine
|
April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome
Zi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Journal of Medicinal Chemistry
|
June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials
Thomas H Marsilje, Wei Pei, Bei Chen, et al.
Cancer Discovery
|
June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Phillip M Rappold, Lynda Vuong, Josef Leibold, et al.
The American Journal of Surgical Pathology
|
January 9, 2018
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma
Chisato Ohe, Steven C Smith, Deepika Sirohi, et al.
Page
of 64